首页 > 最新文献

Diseases of the Colon & Rectum最新文献

英文 中文
What To Do With Suspected Nodal Regrowth on Magnetic Resonance Imaging During Follow-up in an Organ Preservation Approach for Rectal Cancer? 在直肠癌保留器官随访期间,如何处理磁共振成像中的可疑结节再生?
IF 3.9 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-06 DOI: 10.1097/dcr.0000000000003385
Barbara M Geubels,Monique Maas,Geerard L Beets,Brechtje A Grotenhuis,
BACKGROUNDFor nodal regrowth in patients with rectal cancer following watch-and-wait standardized protocols on diagnostic procedures and subsequent treatment are lacking.OBJECTIVEEvaluate the diagnosis and treatment of suspected nodal regrowth following an organ preservation approach.SETTINGSPatients were included from national and institutional watch-and-wait -databases.DESIGNThirty-five rectal cancer patients with suspected nodal regrowth on magnetic resonance imaging were retrospectively identified during watch-and-wait follow-up.PATIENTSTwenty-seven of 35 patients followed watch-and-wait after neoadjuvant (chemo)radiotherapy and 8/35 followed watch-and-wait schedule after local excision for early rectal cancer.MAIN OUTCOME MEASURESDiagnostic procedures, treatment and histopathological outcome.RESULTSMedian follow-up was 34 months. Median time from end of (chemo)radiotherapy or local excision to first detection of suspected nodal regrowth on magnetic resonance imaging following watch-and-wait was 9 and 10 months. After first detection, 17 of 35 patients underwent immediate treatment without further diagnostics, of whom 7 also had luminal regrowth. In 18 of 35 patients, additional diagnostic procedures were performed. In 4 of 18 patients, positron emission tomography-computed tomography or endorectal ultrasound-guided biopsy was performed and treatment was initiated based on increased nodal regrowth suspicion. In 14 of 18 patients, MRI was repeated after 8-12 weeks: growth of suspected lymph nodes was the most decisive factor to proceed to treatment. In 8 patients, repeated magnetic resonance imaging was combined with positron emission tomography-computed tomography and/or endorectal ultrasound-guided biopsy: in half of them it contributed to treatment initiation. In total, 34/35 patients were treated: 9 received (re-)irradiation and 33 underwent total mesorectal excision. In 27 of 33 patients, nodal regrowth was pathologically confirmed in the total mesorectal excision-resection specimen; 5 of 6 patients without nodal involvement had pathologically confirmed luminal regrowth.LIMITATIONSHighly selected study population.CONCLUSIONSDuring watch-and-wait follow-up of patients with rectal cancer in an organ preservation strategy, magnetic resonance imaging plays an important role in diagnosis of nodal regrowth. Repeated magnetic resonance imaging after an interval can be helpful in making treatment decisions, and the role of positron emission tomography-computed tomography and endorectal ultrasound-guided biopsy appears limited. See Video Abstract.
背景对于观察-等待后直肠癌患者的结节再生,缺乏标准化的诊断程序和后续治疗方案。患者35例患者中有27例在新辅助(化疗)放疗后进行了观察和等待,8/35的患者在早期直肠癌局部切除术后进行了观察和等待.主要结局测量诊断程序、治疗和组织病理学结果.结果中位随访时间为34个月。从(化疗)放疗或局部切除术结束到观察等待后首次通过磁共振成像发现疑似结节再生的中位时间分别为9个月和10个月。首次发现后,35 名患者中有 17 人立即接受了治疗,未做进一步诊断,其中 7 人还出现了管腔再生。35 名患者中有 18 人接受了额外的诊断程序。在 18 名患者中,有 4 人进行了正电子发射计算机断层扫描或肛门直肠内超声引导活检,并根据结节再生嫌疑的增加开始治疗。18 例患者中有 14 例在 8-12 周后再次进行了磁共振成像检查:疑似淋巴结生长是进行治疗的最决定性因素。在 8 名患者中,重复磁共振成像与正电子发射断层扫描-计算机断层扫描和/或肛门直肠内超声引导活检相结合:其中半数患者的磁共振成像有助于开始治疗。共有 34/35 名患者接受了治疗:9名患者接受了(再)照射,33名患者接受了全直肠系膜切除术。在 33 例患者中,有 27 例患者的全直肠系膜切除-切除标本经病理证实为结节再生;在 6 例未受结节累及的患者中,有 5 例经病理证实为管腔再生。间隔一段时间后重复磁共振成像有助于做出治疗决定,而正电子发射断层扫描-计算机断层扫描和肛门直肠内超声引导活检的作用似乎有限。参见视频摘要。
{"title":"What To Do With Suspected Nodal Regrowth on Magnetic Resonance Imaging During Follow-up in an Organ Preservation Approach for Rectal Cancer?","authors":"Barbara M Geubels,Monique Maas,Geerard L Beets,Brechtje A Grotenhuis,","doi":"10.1097/dcr.0000000000003385","DOIUrl":"https://doi.org/10.1097/dcr.0000000000003385","url":null,"abstract":"BACKGROUNDFor nodal regrowth in patients with rectal cancer following watch-and-wait standardized protocols on diagnostic procedures and subsequent treatment are lacking.OBJECTIVEEvaluate the diagnosis and treatment of suspected nodal regrowth following an organ preservation approach.SETTINGSPatients were included from national and institutional watch-and-wait -databases.DESIGNThirty-five rectal cancer patients with suspected nodal regrowth on magnetic resonance imaging were retrospectively identified during watch-and-wait follow-up.PATIENTSTwenty-seven of 35 patients followed watch-and-wait after neoadjuvant (chemo)radiotherapy and 8/35 followed watch-and-wait schedule after local excision for early rectal cancer.MAIN OUTCOME MEASURESDiagnostic procedures, treatment and histopathological outcome.RESULTSMedian follow-up was 34 months. Median time from end of (chemo)radiotherapy or local excision to first detection of suspected nodal regrowth on magnetic resonance imaging following watch-and-wait was 9 and 10 months. After first detection, 17 of 35 patients underwent immediate treatment without further diagnostics, of whom 7 also had luminal regrowth. In 18 of 35 patients, additional diagnostic procedures were performed. In 4 of 18 patients, positron emission tomography-computed tomography or endorectal ultrasound-guided biopsy was performed and treatment was initiated based on increased nodal regrowth suspicion. In 14 of 18 patients, MRI was repeated after 8-12 weeks: growth of suspected lymph nodes was the most decisive factor to proceed to treatment. In 8 patients, repeated magnetic resonance imaging was combined with positron emission tomography-computed tomography and/or endorectal ultrasound-guided biopsy: in half of them it contributed to treatment initiation. In total, 34/35 patients were treated: 9 received (re-)irradiation and 33 underwent total mesorectal excision. In 27 of 33 patients, nodal regrowth was pathologically confirmed in the total mesorectal excision-resection specimen; 5 of 6 patients without nodal involvement had pathologically confirmed luminal regrowth.LIMITATIONSHighly selected study population.CONCLUSIONSDuring watch-and-wait follow-up of patients with rectal cancer in an organ preservation strategy, magnetic resonance imaging plays an important role in diagnosis of nodal regrowth. Repeated magnetic resonance imaging after an interval can be helpful in making treatment decisions, and the role of positron emission tomography-computed tomography and endorectal ultrasound-guided biopsy appears limited. See Video Abstract.","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142201258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radially Emitting Diode Laser Closure of Transsphincteric Fistula-in-Ano. 经肛门括约肌瘘的径向发射二极管激光闭合术
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-06 DOI: 10.1097/DCR.0000000000003501
Scott R Kelley, Robert A Vierkant, Jennifer M Russell, Kayleigh M Cummings, Shannon R Berndt

Background: There has been a shift in the treatment of fistula-in-ano towards a focus on preservation of continence while simultaneously eradicating disease. Utilization of radially emitting diode laser catheters to ablate fistula tracks has been described since 2011 with heterogenous studies publishing success rates ranging from 20% to 89%.

Objective: Present our experience managing solitary transsphincteric fistulas of cryptoglandular origin with radially emitting diode laser.

Design: Prospective non-randomized single center trial with 12-month follow-up.

Settings: Quaternary referral academic healthcare center.

Patients: Forty-six adults with transsphincteric fistula-in-ano.

Interventions: All underwent radially emitting diode laser closure of fistula-in-ano.

Main outcome measures: Clinical healing and fistula recurrence.

Results: Forty-six patients with a median age of 48 years (range, 26-85) underwent diode laser closure. Most were men (n = 28/60%). Twenty-four (52%) had previous fistula repairs with a median of 1.5 (range, 1-7) repairs per patient. All were followed for 12 months. Successful closure following one laser treatment occurred in 43%. Thirteen of 26 failures (50%) were able to undergo a delayed fistulotomy secondary to an anatomic change with the fistula becoming more superficial moving out of internal sphincter muscle following laser ablation, all of which healed. No patients experienced new or worsening (preexisting) fecal incontinence. Two (8%) continued treatment for abscesses / fistula branching. One (3%) experienced migration of the fistula from the base of the left labia to the introitus of the vagina and 1 experienced recurrence and worsening of their disease process with subsequent involvement of the coccyx (previous deep postanal space abscess).

Limitations: Limitations to our study include its non-randomized prospective nature, single center and surgeon experience, and small patient sample size.

Conclusions: Radially emitting diode laser closure is a continence preserving option to consider when treating transsphincteric fistula-in-ano. When the procedure fails it does not fail poorly (open wounds, retracted flaps, incontinence, etc.), and can be repeated. Complications can include abscess formation and fistula migration to adjacent anatomic locations (vagina). Even if not successful, following treatment the fistula can anatomically migrate distally becoming more superficial and thus providing the opportunity to proceed with a delayed fistulotomy. See Video Abstract.

背景:肛瘘治疗的重点已转向在根除疾病的同时保留肛门通畅。自 2011 年以来,利用径向发射二极管激光导管消融瘘管径迹的方法已被描述,不同研究发表的成功率从 20% 到 89% 不等:介绍我们使用径向发射二极管激光治疗隐腺体源性单发经括约肌瘘的经验:设计:前瞻性非随机单中心试验,随访12个月:设置:四级转诊学术医疗中心:46名成人经括约肌肛瘘患者:干预措施:所有患者均接受径向发射二极管激光闭合肛瘘:主要结果测量:临床愈合和瘘管复发:46名患者接受了二极管激光闭合术,中位年龄为48岁(26-85岁)。大多数患者为男性(28/60%)。24名患者(52%)曾接受过瘘管修补术,每位患者的中位修补次数为1.5次(1-7次)。所有患者均接受了 12 个月的随访。43%的患者在一次激光治疗后成功闭合瘘管。在 26 例失败患者中,有 13 例(50%)在激光消融后,由于瘘管从内括约肌移出,瘘管变得更加浅表,导致解剖结构发生变化,因此能够接受延迟瘘管切开术,所有患者的瘘管均已愈合。没有患者出现新的或恶化的(原有的)大便失禁。两名患者(8%)因脓肿/瘘管分支而继续接受治疗。1名患者(3%)的瘘管从左侧阴唇基部移至阴道内口,1名患者的病情复发和恶化,随后累及尾骨(之前的肛门后深间隙脓肿):我们研究的局限性包括其非随机前瞻性、单一中心和外科医生经验以及患者样本量较小:结论:径向发射二极管激光闭合术是治疗经肛门括约肌性肛瘘时可考虑的一种保护尿失禁的方法。当手术失败时,其失败率并不低(开放性伤口、皮瓣回缩、失禁等),而且可以重复进行。并发症包括脓肿形成和瘘管移位到邻近的解剖位置(阴道)。即使治疗不成功,瘘管也会向远端解剖移位,变得更加浅表,从而提供了进行延迟瘘管切开术的机会。参见视频摘要。
{"title":"Radially Emitting Diode Laser Closure of Transsphincteric Fistula-in-Ano.","authors":"Scott R Kelley, Robert A Vierkant, Jennifer M Russell, Kayleigh M Cummings, Shannon R Berndt","doi":"10.1097/DCR.0000000000003501","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003501","url":null,"abstract":"<p><strong>Background: </strong>There has been a shift in the treatment of fistula-in-ano towards a focus on preservation of continence while simultaneously eradicating disease. Utilization of radially emitting diode laser catheters to ablate fistula tracks has been described since 2011 with heterogenous studies publishing success rates ranging from 20% to 89%.</p><p><strong>Objective: </strong>Present our experience managing solitary transsphincteric fistulas of cryptoglandular origin with radially emitting diode laser.</p><p><strong>Design: </strong>Prospective non-randomized single center trial with 12-month follow-up.</p><p><strong>Settings: </strong>Quaternary referral academic healthcare center.</p><p><strong>Patients: </strong>Forty-six adults with transsphincteric fistula-in-ano.</p><p><strong>Interventions: </strong>All underwent radially emitting diode laser closure of fistula-in-ano.</p><p><strong>Main outcome measures: </strong>Clinical healing and fistula recurrence.</p><p><strong>Results: </strong>Forty-six patients with a median age of 48 years (range, 26-85) underwent diode laser closure. Most were men (n = 28/60%). Twenty-four (52%) had previous fistula repairs with a median of 1.5 (range, 1-7) repairs per patient. All were followed for 12 months. Successful closure following one laser treatment occurred in 43%. Thirteen of 26 failures (50%) were able to undergo a delayed fistulotomy secondary to an anatomic change with the fistula becoming more superficial moving out of internal sphincter muscle following laser ablation, all of which healed. No patients experienced new or worsening (preexisting) fecal incontinence. Two (8%) continued treatment for abscesses / fistula branching. One (3%) experienced migration of the fistula from the base of the left labia to the introitus of the vagina and 1 experienced recurrence and worsening of their disease process with subsequent involvement of the coccyx (previous deep postanal space abscess).</p><p><strong>Limitations: </strong>Limitations to our study include its non-randomized prospective nature, single center and surgeon experience, and small patient sample size.</p><p><strong>Conclusions: </strong>Radially emitting diode laser closure is a continence preserving option to consider when treating transsphincteric fistula-in-ano. When the procedure fails it does not fail poorly (open wounds, retracted flaps, incontinence, etc.), and can be repeated. Complications can include abscess formation and fistula migration to adjacent anatomic locations (vagina). Even if not successful, following treatment the fistula can anatomically migrate distally becoming more superficial and thus providing the opportunity to proceed with a delayed fistulotomy. See Video Abstract.</p>","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Localized Administration of Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Refractory Perianal Fistula in Crohn's Disease Patients: A Phase II Clinical Trial. 局部应用间充质干细胞衍生的外泌体治疗克罗恩病患者的难治性肛周瘘:II期临床试验。
IF 3.9 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-06 DOI: 10.1097/dcr.0000000000003502
Alireza Hadizadeh,Reza Akbari-Asbagh,Asieh Heirani-Tabasi,Masoud Soleimani,Parastou Gorovanchi,Nasser Ebrahimi Daryani,Amir Vahedi,Hengameh Nazari,Seyedeh-Parnian Banikarimi,Mahnoosh Abbaszade-Dibavar,Behnam Behboudi,Mohammad Sadegh Fazeli,Mohammad Reza Keramati,Amir Keshvari,Alireza Kazemeini,Haleh Pak,Amir-Reza Fazeli,Foroogh Alborzi,Seyed-Mohsen Ahmadi-Tafti
BACKGROUNDCrohn's disease perianal fistulae are often resistant to standard anti-TNF-α therapies. Mesenchymal stem cell (MSC)-derived exosomes are extracellular vesicles that have highly potent anti-inflammatory effects, and the previous phase of this study demonstrated their safety in the treatment of refractory perianal fistulas.OBJECTIVETo evaluate the efficacy of mesenchymal stem cell-derived exosomes for the treatment of refractory perianal fistulas.DESIGNNonrandomized, nonblinded single-center phase II clinical trial.SETTINGSTertiary university hospital.PATIENTSTwenty-three patients were enrolled, 20 of whom completed the study. Refractory perianal fistula was defined as resistance to at least one course of treatment with anti-tumor necrosis facto-α therapy.INTERVENTIONSAfter clinical assessment and magnetic resonance imaging, the patients were subjected to general anesthesia, and 5 mL of exosome solution was injected directly into the fistula tracts. The injections were repeated three times at 2-month intervals, and patients were followed monthly for 6 months after the last injection. Tissue samples from the tracts were obtained before each injection and subjected to immunohistopathological assessment. MRI data were obtained before and six months after the last injection.MAIN OUTCOME MEASURESThe primary outcome of this study was fistula tract closure on clinical examination and magnetic resonance imaging. The secondary outcome was an improvement in the discharge from the tracts.RESULTSFistula tracts were fully closed in 12 (60%) of the patients. Four patients showed clinical improvement, with some tracts remaining open, and four patients were completely resistant to treatment. A total of 43 fistula tracts were treated during the trial, 30 (69.7%) of which showed complete closure. Histopathological analysis revealed substantial reductions in local inflammation and signs of enhanced tissue regeneration. Immunohistochemical analysis of cluster of differentiation-68, 20 and 31 reaffirmed these results.CONCLUSIONSMSC-derived exosomes are safe and effective for treating refractory perianal fistulas in patients with Crohn's disease. See Video Abstract.
背景克罗恩病肛周瘘通常对标准的抗肿瘤坏死因子-α疗法产生抗药性。间充质干细胞(MSC)衍生的外泌体是一种细胞外囊泡,具有很强的抗炎作用,本研究的前一阶段证明了它们在治疗难治性肛周瘘中的安全性。目的评估间充质干细胞衍生外泌体治疗难治性肛周瘘的疗效。设计非随机、非盲法单中心II期临床试验。难治性肛周瘘的定义是至少一个疗程的抗肿瘤坏死因子-α治疗无效。在最后一次注射后的 6 个月内,每月对患者进行随访。每次注射前从瘘道中获取组织样本,并进行免疫组织病理学评估。主要结果测量本研究的主要结果是临床检查和磁共振成像显示的瘘道闭合情况。结果12 名患者(60%)的瘘道完全闭合。4名患者的临床症状有所改善,但部分瘘管仍未闭合,4名患者对治疗完全耐药。试验期间共治疗了 43 个瘘道,其中 30 个(69.7%)完全闭合。组织病理学分析显示,局部炎症明显减轻,组织再生迹象增强。分化簇-68、20和31的免疫组化分析再次证实了这些结果。结论MSC衍生外泌体对于治疗克罗恩病患者的难治性肛周瘘是安全有效的。参见视频摘要。
{"title":"Localized Administration of Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Refractory Perianal Fistula in Crohn's Disease Patients: A Phase II Clinical Trial.","authors":"Alireza Hadizadeh,Reza Akbari-Asbagh,Asieh Heirani-Tabasi,Masoud Soleimani,Parastou Gorovanchi,Nasser Ebrahimi Daryani,Amir Vahedi,Hengameh Nazari,Seyedeh-Parnian Banikarimi,Mahnoosh Abbaszade-Dibavar,Behnam Behboudi,Mohammad Sadegh Fazeli,Mohammad Reza Keramati,Amir Keshvari,Alireza Kazemeini,Haleh Pak,Amir-Reza Fazeli,Foroogh Alborzi,Seyed-Mohsen Ahmadi-Tafti","doi":"10.1097/dcr.0000000000003502","DOIUrl":"https://doi.org/10.1097/dcr.0000000000003502","url":null,"abstract":"BACKGROUNDCrohn's disease perianal fistulae are often resistant to standard anti-TNF-α therapies. Mesenchymal stem cell (MSC)-derived exosomes are extracellular vesicles that have highly potent anti-inflammatory effects, and the previous phase of this study demonstrated their safety in the treatment of refractory perianal fistulas.OBJECTIVETo evaluate the efficacy of mesenchymal stem cell-derived exosomes for the treatment of refractory perianal fistulas.DESIGNNonrandomized, nonblinded single-center phase II clinical trial.SETTINGSTertiary university hospital.PATIENTSTwenty-three patients were enrolled, 20 of whom completed the study. Refractory perianal fistula was defined as resistance to at least one course of treatment with anti-tumor necrosis facto-α therapy.INTERVENTIONSAfter clinical assessment and magnetic resonance imaging, the patients were subjected to general anesthesia, and 5 mL of exosome solution was injected directly into the fistula tracts. The injections were repeated three times at 2-month intervals, and patients were followed monthly for 6 months after the last injection. Tissue samples from the tracts were obtained before each injection and subjected to immunohistopathological assessment. MRI data were obtained before and six months after the last injection.MAIN OUTCOME MEASURESThe primary outcome of this study was fistula tract closure on clinical examination and magnetic resonance imaging. The secondary outcome was an improvement in the discharge from the tracts.RESULTSFistula tracts were fully closed in 12 (60%) of the patients. Four patients showed clinical improvement, with some tracts remaining open, and four patients were completely resistant to treatment. A total of 43 fistula tracts were treated during the trial, 30 (69.7%) of which showed complete closure. Histopathological analysis revealed substantial reductions in local inflammation and signs of enhanced tissue regeneration. Immunohistochemical analysis of cluster of differentiation-68, 20 and 31 reaffirmed these results.CONCLUSIONSMSC-derived exosomes are safe and effective for treating refractory perianal fistulas in patients with Crohn's disease. See Video Abstract.","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142201259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How do you code colonoscopies correctly? 如何正确编码结肠镜检查?
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-06 DOI: 10.1097/DCR.0000000000003533
Donald B Colvin, Kelly M Tyler
{"title":"How do you code colonoscopies correctly?","authors":"Donald B Colvin, Kelly M Tyler","doi":"10.1097/DCR.0000000000003533","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003533","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introducing Colorectal Coding Corner! 介绍结肠直肠编码角!
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-06 DOI: 10.1097/DCR.0000000000003532
Kelly M Tyler, Donald Colvin
{"title":"Introducing Colorectal Coding Corner!","authors":"Kelly M Tyler, Donald Colvin","doi":"10.1097/DCR.0000000000003532","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003532","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142139604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initial Experience With Single-Port Robotic Right Colectomies: Results of an Investigator-Initiated Investigational Device Exemption Study Using a Novel Single-Port Robotic Platform. 单孔机器人右结肠切除术的初步经验:使用新型单孔机器人平台的研究者发起的研究性设备豁免研究结果。
IF 3.9 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-05 DOI: 10.1097/dcr.0000000000003352
Ankit Sarin,Katherine E Barnes,Amy M Shui,Yukino Nakamura,Daniel B Hoffman,Fernanda Romero-Hernandez,Hueylan Chern
BACKGROUNDMinimally invasive surgical techniques have been widely adopted in colorectal surgery. New technological breakthroughs have led to even less invasive alternatives like single-port surgery, but this has been hindered by technical challenges such as the collision of robotic arms within a limited space. The Intuitive da Vinci Single-Port robotic platform is a novel system that overcomes some of these challenges.IMPACT OF INNOVATIONThis study aimed to assess the safety and feasibility of the Intuitive da Vinci Single-Port robotic platform in right segmental colectomies among adult patients. These findings may set the stage for more widespread use of single-port robotic surgery.TECHNOLOGY, MATERIALS, AND METHODSThe Intuitive da Vinci Single-Port robot is a system designed specifically for single-port robotic surgery. This platform enables flexible port location and efficient internal and external range of motion using a single C-shaped arm. In the present study, right colectomies were performed in adult patients using this platform between May 2022 and November 2022, and they were compared to right colectomies in adult patients performed using the standard multiport platform between January 2019 and December 2022. The main outcome measure was safety and quality event rates.PRELIMINARY RESULTSOf 30 patients, 16.7% of patients (n = 5) underwent single-port robotic right colectomy and 83.3% (n = 25) underwent multiport right colectomy. In the single-port group, 40% of patients (n = 2) developed a safety/quality event (postoperative portal vein thrombosis and excessive postoperative pain). In the multiport group, 32% of patients (n = 8) developed 1 safety/quality event and 8% (n = 2) had more than 1 event.CONCLUSIONS AND FUTURE DIRECTIONSThis preliminary study, one of the first Food and Drug Administration-approved, investigator-initiated uses of this platform in colorectal surgeries, shows that this platform is a safe and feasible option for right colectomies. On preliminary evaluation, it appears comparable in terms of relevant safety/quality events to the multiport platform.CLINICAL TRIAL REGISTRATIONClinicaltrials.gov NCT05321134.
背景微创外科技术已在结直肠外科中广泛采用。新技术的突破带来了单孔手术等创伤更小的替代技术,但这一技术一直受到技术挑战的阻碍,例如机器人手臂在有限空间内的碰撞。本研究旨在评估直觉达芬奇单孔机器人平台在成年患者右段结肠切除术中的安全性和可行性。技术、材料和方法直观达芬奇单孔机器人是专为单孔机器人手术设计的系统。该平台可通过单个 C 形臂实现灵活的端口位置和高效的内外活动范围。在本研究中,2022 年 5 月至 2022 年 11 月期间,使用该平台为成年患者实施了右结肠切除术,并与 2019 年 1 月至 2022 年 12 月期间使用标准多孔平台为成年患者实施的右结肠切除术进行了比较。主要结果指标为安全性和质量事件发生率。初步结果 在30名患者中,16.7%的患者(n = 5)接受了单孔机器人右结肠切除术,83.3%的患者(n = 25)接受了多孔右结肠切除术。在单孔组中,40%的患者(n = 2)发生了安全/质量事件(术后门静脉血栓形成和术后过度疼痛)。结论和未来方向这项初步研究是经食品和药物管理局批准、由研究者发起在结直肠手术中使用该平台的首批研究之一,研究结果表明该平台是右结肠切除术中安全可行的选择。经初步评估,该平台在相关安全性/质量事件方面与多孔平台相当。
{"title":"Initial Experience With Single-Port Robotic Right Colectomies: Results of an Investigator-Initiated Investigational Device Exemption Study Using a Novel Single-Port Robotic Platform.","authors":"Ankit Sarin,Katherine E Barnes,Amy M Shui,Yukino Nakamura,Daniel B Hoffman,Fernanda Romero-Hernandez,Hueylan Chern","doi":"10.1097/dcr.0000000000003352","DOIUrl":"https://doi.org/10.1097/dcr.0000000000003352","url":null,"abstract":"BACKGROUNDMinimally invasive surgical techniques have been widely adopted in colorectal surgery. New technological breakthroughs have led to even less invasive alternatives like single-port surgery, but this has been hindered by technical challenges such as the collision of robotic arms within a limited space. The Intuitive da Vinci Single-Port robotic platform is a novel system that overcomes some of these challenges.IMPACT OF INNOVATIONThis study aimed to assess the safety and feasibility of the Intuitive da Vinci Single-Port robotic platform in right segmental colectomies among adult patients. These findings may set the stage for more widespread use of single-port robotic surgery.TECHNOLOGY, MATERIALS, AND METHODSThe Intuitive da Vinci Single-Port robot is a system designed specifically for single-port robotic surgery. This platform enables flexible port location and efficient internal and external range of motion using a single C-shaped arm. In the present study, right colectomies were performed in adult patients using this platform between May 2022 and November 2022, and they were compared to right colectomies in adult patients performed using the standard multiport platform between January 2019 and December 2022. The main outcome measure was safety and quality event rates.PRELIMINARY RESULTSOf 30 patients, 16.7% of patients (n = 5) underwent single-port robotic right colectomy and 83.3% (n = 25) underwent multiport right colectomy. In the single-port group, 40% of patients (n = 2) developed a safety/quality event (postoperative portal vein thrombosis and excessive postoperative pain). In the multiport group, 32% of patients (n = 8) developed 1 safety/quality event and 8% (n = 2) had more than 1 event.CONCLUSIONS AND FUTURE DIRECTIONSThis preliminary study, one of the first Food and Drug Administration-approved, investigator-initiated uses of this platform in colorectal surgeries, shows that this platform is a safe and feasible option for right colectomies. On preliminary evaluation, it appears comparable in terms of relevant safety/quality events to the multiport platform.CLINICAL TRIAL REGISTRATIONClinicaltrials.gov NCT05321134.","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142201260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Evaluation and Management of Chronic Constipation. 美国结肠和直肠外科医生学会《慢性便秘的评估和治疗临床实践指南》。
IF 3.9 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-05 DOI: 10.1097/dcr.0000000000003430
Karim Alavi,Amy J Thorsen,Sandy H Fang,Pamela L Burgess,Gino Trevisani,Amy L Lightner,Daniel L Feingold,Ian M Paquette,
{"title":"The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Evaluation and Management of Chronic Constipation.","authors":"Karim Alavi,Amy J Thorsen,Sandy H Fang,Pamela L Burgess,Gino Trevisani,Amy L Lightner,Daniel L Feingold,Ian M Paquette,","doi":"10.1097/dcr.0000000000003430","DOIUrl":"https://doi.org/10.1097/dcr.0000000000003430","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":null,"pages":null},"PeriodicalIF":3.9,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142201261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating Compliance With National Comprehensive Cancer Network Guidelines in Lynch Syndrome. 评估林奇综合征患者对国家综合癌症网络指南的遵守情况。
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-04 DOI: 10.1097/DCR.0000000000003393
Rohith S Raman, Benjamin Usry, Kevin S Hughes, Colleen Donahue
{"title":"Evaluating Compliance With National Comprehensive Cancer Network Guidelines in Lynch Syndrome.","authors":"Rohith S Raman, Benjamin Usry, Kevin S Hughes, Colleen Donahue","doi":"10.1097/DCR.0000000000003393","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003393","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neoadjuvant Therapy for Colon Cancer. 结肠癌新辅助疗法
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-04 DOI: 10.1097/DCR.0000000000003524
Lauren Weaver, Paolo Goffredo
{"title":"Neoadjuvant Therapy for Colon Cancer.","authors":"Lauren Weaver, Paolo Goffredo","doi":"10.1097/DCR.0000000000003524","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003524","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Perspective on "Social Determinants of Health in Diverticulitis: A Systematic Review". 憩室炎健康的社会决定因素 "的研究视角:系统回顾"。
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-09-04 DOI: 10.1097/DCR.0000000000003469
Ira L Leeds
{"title":"Research Perspective on \"Social Determinants of Health in Diverticulitis: A Systematic Review\".","authors":"Ira L Leeds","doi":"10.1097/DCR.0000000000003469","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003469","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142132140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diseases of the Colon & Rectum
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1